Clinical trialPhase 2Terminated
Trial of Neoadjuvant Chemotherapy With S1 Plus Paclitaxel-albumin on Pancreatic Cancer
Clinical Trial of Neoadjuvant Chemotherapy With S1 Plus Paclitaxel-albumin in Patients With Unresectable Locally Advanced Pancreatic Cancer
- Outcome
- Stopped earlyThe paclitaxel-albumin halt production. (Other)
- Phase
- Phase 2
- Status
- Terminated
- Study type
- Interventional
- Start
- 20 November 2017
- Expected end
- 1 July 2019
- Enrollment
- 40 participants
- Sites
- 1
- Primary outcomes
- R0 resection rate
- Sponsor
- Other
- Results posted
- No
- Last update
- 8 January 2021
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try